JPRN-UMIN000004617已完成1 期
Combined modality treatment for patients with stage IV melanoma: Cyclophosphamide and a dendritic cell vaccine loaded with killed allogeneic melanoma cells - Combination of cyclophosphamide and a dendritic cell vaccine for stage IV melanoma
Department of Hematology and Oncology, Kyoto University Hospital0 个研究点目标入组 10 人开始时间: 2011年1月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 21years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with a history of neoplasitic disease other than melanoma within 5 years 2. Patients with a history of autoimmune disease 3. Patients with unstable angina pectoris, congestive heart failure, asthma or active systemic infection 4. Positive for HBs Ag, HCV Ab, HTLV-I Ab, HIV Ab, or serological test for syphilis
研究者
相似试验
已完成
4 期
Combination drug therapy for fibromyalgia paiMusculoskeletal DiseasesOther soft tissue disorders, not elsewhere classifiedFibromyalgiaISRCTN20173707Queen's University (Canada)69
未知
3 期
Clinical investigation for combination therapy of KAD-1229 and Pioglitazone.Type 2 diabetesJPRN-jRCT2080220136KISSEI PHARMACEUTICAL CO.,LTD.
进行中（未招募）
不适用
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
已完成
不适用
Consideration of combination therapy with both vorinostat and ultraviolet therapy for cutaneous T-cell lymphoma patientsCutaneous T-cell lymphoma, Mycosis fungoides, Sezary's syndromeJPRN-UMIN000010590Department of Dermatology, Okayama University3
招募中
不适用
Clinical investigation of combination therapy with a1 blocker and vibegron for treating overactive bladder in patients with benign prostatic hyperplasiaoveractive bladderJPRN-UMIN000039150Koto Hospital, Dept. of Urology50